|
WO2007075871A2
|
|
Processes for reducing particle size of aripiprazole
|
|
WO2007044950A2
|
|
Crystalline forms of docetaxel and processes for their preparation
|
|
US2007088082A1
|
|
Polymorphic forms of ladostigil tartrate
|
|
US2007098804A1
|
|
Solid particulate tadalafil having a bimodal particle size distribution
|
|
US2007265456A1
|
|
Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
|
|
US2006270685A1
|
|
Anhydrous ziprasidone mesylate and a process for its preparation
|
|
US2006270684A1
|
|
Crystalline forms of ziprasidone mesylate
|
|
US2006160785A1
|
|
Ezetimibe polymorphs
|
|
WO2006055964A2
|
|
Zolmitriptan crystal forms
|
|
WO2006012379A2
|
|
Processes for preparation of crystalline mycophenolate sodium
|
|
WO2005058819A2
|
|
Polymorphic forms of tegaserod base and salts thereof
|
|
WO2004080461A2
|
|
Stable pharmaceutical compositions of desloratadine
|
